rdf:type |
|
lifeskim:mentions |
umls-concept:C0005516,
umls-concept:C0007222,
umls-concept:C0011570,
umls-concept:C0032105,
umls-concept:C0035648,
umls-concept:C0056077,
umls-concept:C0087111,
umls-concept:C0221423,
umls-concept:C0441994,
umls-concept:C0518656,
umls-concept:C0683598
|
pubmed:issue |
4
|
pubmed:dateCreated |
2010-1-13
|
pubmed:abstractText |
There is now evidence that major depression is accompanied by an induction of inflammatory and oxidative and nitrosative stress (IO&NS) pathways and by a lowered antioxidant status. Coenzyme Q10 (CoQ10) is a strong antioxidant that has anti-inflammatory effects.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0172-780X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
462-9
|
pubmed:meshHeading |
pubmed-meshheading:20010493-Adult,
pubmed-meshheading:20010493-Antidepressive Agents,
pubmed-meshheading:20010493-Biological Markers,
pubmed-meshheading:20010493-Cardiovascular Diseases,
pubmed-meshheading:20010493-Chronic Disease,
pubmed-meshheading:20010493-Depressive Disorder, Major,
pubmed-meshheading:20010493-Drug Resistance,
pubmed-meshheading:20010493-Fatigue,
pubmed-meshheading:20010493-Female,
pubmed-meshheading:20010493-Humans,
pubmed-meshheading:20010493-Male,
pubmed-meshheading:20010493-Middle Aged,
pubmed-meshheading:20010493-Oxidative Stress,
pubmed-meshheading:20010493-Risk Factors,
pubmed-meshheading:20010493-Ubiquinone,
pubmed-meshheading:20010493-Vasculitis
|
pubmed:year |
2009
|
pubmed:articleTitle |
Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness.
|
pubmed:affiliation |
Maes Clinics, Antwerp, Belgium. crc.mh@telenet.be
|
pubmed:publicationType |
Journal Article
|